Together, this work highlights the potential use ofPINK1 activatorsthat induce PINK1-dependent mitophagy and prevent high levels of phosphorylatedubiquitin caused by mitochondrial damaging agents as treatments ofidiopathic PD. Here, PINK1 is linked to Parkinson disease.